What is the price-to-earnings ratio of Evogene?
The price-earnings ratio of Evogene is currently 0.59.
Evogene P/S 2024
Evogene P/S
0.59
Ticker
EVGN
ISIN
IL0011050551
WKN
A0Q7UP
As of Oct 2, 2024, Evogene's P/S ratio stood at 0.59, a -55.64% change from the 1.33 P/S ratio recorded in the previous year.
The Evogene P/S history
Evogene Aktienanalyse
What does Evogene do?
Evogene Ltd is an Israeli biotechnology company that focuses on the application of computational biology and genomics to agriculture and biology. The company originated from a spin-off of the Weizmann Institute of Science and was founded in 2002. Today, it is a leading global provider of biotechnology solutions for the agriculture and biotechnology industry. Evogene's business model is based on providing innovative technologies and services for its customers, aiming to improve plant development, particularly in terms of resistance to environmental stress factors and pests. To achieve this, the company utilizes modern biotechnology methods and leverages artificial intelligence. It employs advanced machine learning and large-scale data analysis techniques to gain a better understanding of underlying biological processes. Evogene operates in three core areas: agricultural biotechnology, drug discovery biotechnology, and biomaterials. The company is capable of offering customized biological solutions tailored to the specific needs of its customers. Agricultural biotechnology is one of Evogene's key sectors. It utilizes state-of-the-art technologies and methods to generate plant resistance to pests and environmental factors. With the help of a reliable pipeline of innovative products such as seeds, biostimulants, and fertilizers, Evogene aims to play an important role in food security, environmental sustainability, and resilience to climate change. The company has a strong product pipeline aimed at improving nutrient efficiency of crops while reducing environmental impact from pesticide and fertilizer use. One such product resulting from this pipeline is EvoCanna, which utilizes modern genomics methods to optimize hemp plants in terms of phytocannabinoid biosynthesis. The goal of Evogene's drug discovery biotechnology and biomaterials sector is to develop innovative and effective medicines for diseases such as cancer and obesity. The company utilizes modern machine learning and large-scale data analysis methods to identify the potential of new drug candidates. In the biomaterials sector, Evogene aims to develop innovative technologies and solutions for better and more sustainable use of natural resources. An important application of this concept is biostimulants, which can improve the growth rate, stress tolerance, and yield of crops. Additionally, the company can offer new materials and environmentally friendly solutions in the packaging industry. Overall, Evogene has achieved impressive success in recent years and established itself as a leading biotechnology company. By utilizing cutting-edge technologies, methods, and scientific concepts, particularly artificial intelligence and machine learning, and by operating as a responsible company in the fields of agriculture, biomaterials, and programming, Evogene is able to offer innovative biotechnological solutions. The company is currently well-equipped and has a promising pipeline of groundbreaking innovation projects that embody the desire for a sustainable worldview. Evogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Evogene's P/S Ratio
Evogene's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Evogene's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Evogene's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Evogene’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Evogene stock
How has the price-earnings ratio of Evogene changed compared to last year?
The price-to-earnings ratio of Evogene has increased by -55.64% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Evogene high compared to other companies?
Yes, the price-to-earnings ratio of Evogene is high compared to other companies.
How does an increase in the price-earnings ratio of Evogene affect the company?
An increase in the price-earnings ratio of Evogene would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Evogene affect the company?
A decrease in the price-earnings ratio of Evogene would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Evogene?
Some factors that influence the price-earnings ratio of Evogene are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Evogene pay?
Over the past 12 months, Evogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evogene is expected to pay a dividend of 0 USD.
What is the dividend yield of Evogene?
The current dividend yield of Evogene is .
When does Evogene pay dividends?
Evogene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Evogene?
Evogene paid dividends every year for the past 0 years.
What is the dividend of Evogene?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Evogene located?
Evogene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Evogene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Evogene from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did Evogene pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of Evogene in the year 2023?
In the year 2023, Evogene distributed 0 USD as dividends.
In which currency does Evogene pay out the dividend?
The dividends of Evogene are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Evogene
Our stock analysis for Evogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.